Blog
Speaking up for the ‘silent disease’ in the Asia Pacific
APCO round-up of World Osteoporosis Day 2020 activities Last Tuesday, October 20, 2020, members of the Asia Pacific Consortium on Osteoporosis (APCO) celebrated with...
Osteoporosis and fragility fractures – a family affair
Celebrating World Osteoporosis Day 2020 The Asia Pacific Consortium on Osteoporosis (APCO) is delighted to be celebrating World Osteoporosis Day (WOD) today (Tuesday, October...
Goal Directed Therapy in osteoporosis: a target in sight or still a pipe-dream?
“Goal Directed Therapy” (GDT) is a patient care approach designed to improve patient outcomes, and is well established following its initial introduction in critical care....
Breakable bones and genes – How can doctors utilise genes for fracture risk assessment?
More than 300 genetic variants have been discovered to be associated with osteoporosis or fracture. The magnitude of effect of these variants on fracture risk...
Innovative approaches to driving public awareness of bone health
In December 2012, Osteoporosis New Zealand (ONZ) published BoneCare 2020 which called for implementation of a systematic approach to hip fracture care and prevention for...
Osteopenia – To treat or not to treat. That is the question
Osteopenia is not a disease. It is a category of bone density - between 1 and 2.5 standard deviations below the mean value in the...
Fixing a Fractured Future – Can Artificial Intelligence help?
Since the term was coined by John McCarthy in 1956, Artificial Intelligence (AI), the ability of machines to emulate human cognition in the analysis, interpretation, and comprehension...
Not just garden-variety osteoporosis: secondary osteoporosis and its management
The bone loss and increased bone fragility that results from specific, well-defined clinical disorders, and due to certain medications, is termed secondary osteoporosis. Pre- and...
